BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9180138)

  • 1. Expression of interleukin 15 (IL-15) in human rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma.
    Lollini PL; Palmieri G; De Giovanni C; Landuzzi L; Nicoletti G; Rossi I; Griffoni C; Frabetti F; Scotlandi K; Benini S; Baldini N; Santoni A; Nanni P
    Int J Cancer; 1997 May; 71(5):732-6. PubMed ID: 9180138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells.
    Lollini PL; Landuzzi L; Frabetti F; Rossi I; Nicoletti G; Scotlandi K; Serra M; Baldini N; De Giovanni C; Nanni P
    Clin Cancer Res; 1998 Aug; 4(8):1843-9. PubMed ID: 9717810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.
    Knowles HJ; Schaefer KL; Dirksen U; Athanasou NA
    BMC Cancer; 2010 Jul; 10():372. PubMed ID: 20637078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.
    Antman K; Crowley J; Balcerzak SP; Kempf RA; Weiss RB; Clamon GH; Baker LH
    Cancer; 1998 Apr; 82(7):1288-95. PubMed ID: 9529020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
    Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
    Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical analysis of tasidotin HCl in Ewing's sarcoma, rhabdomyosarcoma, synovial sarcoma, and osteosarcoma.
    Garg V; Zhang W; Gidwani P; Kim M; Kolb EA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5446-54. PubMed ID: 17875774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 and Ewing's sarcoma/PNET: A microarray analysis.
    Fagone P; Nicoletti F; Salvatorelli L; Musumeci G; Magro G
    Acta Histochem; 2015 Oct; 117(8):824-8. PubMed ID: 26363896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
    Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; RĂ©dini F
    Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.
    Giordano G; Merlini A; Ferrero G; Mesiano G; Fiorino E; Brusco S; Centomo ML; Leuci V; D'Ambrosio L; Aglietta M; Sangiolo D; Grignani G; Pignochino Y
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezrin mediates growth and survival in Ewing's sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway.
    Krishnan K; Bruce B; Hewitt S; Thomas D; Khanna C; Helman LJ
    Clin Exp Metastasis; 2006; 23(3-4):227-36. PubMed ID: 17028919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Common Oncogenic Genes and Pathways Both in Osteosarcoma and Ewing's Sarcoma Using Bioinformatics Analysis.
    Zhang J; Huang J; Liu W; Ding L; Cheng D; Xiao H
    J Immunol Res; 2022; 2022():3655908. PubMed ID: 35578666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-germline gene expression in pediatric solid tumors using quantitative real-time PCR.
    Jacobs JF; Brasseur F; Hulsbergen-van de Kaa CA; van de Rakt MW; Figdor CG; Adema GJ; Hoogerbrugge PM; Coulie PG; de Vries IJ
    Int J Cancer; 2007 Jan; 120(1):67-74. PubMed ID: 17019710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
    Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma.
    Bennani-Baiti IM; Machado I; Llombart-Bosch A; Kovar H
    Hum Pathol; 2012 Aug; 43(8):1300-7. PubMed ID: 22245111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 is a useful marker for soft tissue Ewing's sarcoma/peripheral Primitive Neuroectodermal Tumor in children and adolescents: A comparative immunohistochemical study with rhabdomyosarcoma.
    Magro G; Brancato F; Musumeci G; Alaggio R; Parenti R; Salvatorelli L
    Acta Histochem; 2015; 117(4-5):460-7. PubMed ID: 25765111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PROGNOSTIC IMPLICATIONS OF PD-L1 EXPRESSION AND LOSS OF PTEN IN PATIENTS WITH RHABDOMYOSARCOMA, EWING'S SARCOMA AND OSTEOSARCOMA.
    Abd Elmoneim HM; Huwait HF; Nafady-Hego H; Mohamed FA
    Exp Oncol; 2023 Dec; 45(3):337-350. PubMed ID: 38186021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of neural cell adhesion molecules and neurofilament protein isoforms in Ewing's sarcoma of bone and soft tissue sarcomas other than rhabdomyosarcoma.
    Molenaar WM; Muntinghe FL
    Hum Pathol; 1999 Oct; 30(10):1207-12. PubMed ID: 10534169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-12 up-regulates Fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity.
    Zhou Z; Lafleur EA; Koshkina NV; Worth LL; Lester MS; Kleinerman ES
    Mol Cancer Res; 2005 Dec; 3(12):685-91. PubMed ID: 16380506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma.
    Pahl JH; Ruslan SE; Buddingh EP; Santos SJ; Szuhai K; Serra M; Gelderblom H; Hogendoorn PC; Egeler RM; Schilham MW; Lankester AC
    Clin Cancer Res; 2012 Jan; 18(2):432-41. PubMed ID: 22090361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Ecteinascidin-743 against drug-sensitive and -resistant bone tumor cells.
    Scotlandi K; Perdichizzi S; Manara MC; Serra M; Benini S; Cerisano V; Strammiello R; Mercuri M; Reverter-Branchat G; Faircloth G; D'Incalci M; Picci P
    Clin Cancer Res; 2002 Dec; 8(12):3893-903. PubMed ID: 12473605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.